Dr Eppie Yiu and Professor Joshua Burns from the Centre of Research Excellence in Neuromuscular Disorders and the Australasian Neuromuscular Network (ANN) are leading a team of Australian and international experts in the development of a clinical practice guideline for children with Charcot-Marie-Tooth disease (CMT).
The guideline will fill a significant gap in for the care of childhood CMT, setting out recommendations for the management and anticipatory monitoring of children with CMT. The complete guideline will provide evidence-based and consensus-based treatment recommendations for problems associated with CMT, including muscle cramps, weakness, pain and impaired mobility. It will also provide guidance for monitoring common associated conditions such as hip dysplasia, and vision and hearing difficulties.
The guideline development is being overseen by an advisory committee of neuromuscular practitioners and guideline method experts, in consultation with individuals with CMT, and their family members.
Stay tuned for …further updates as the guideline is developed. A public consultation period on the guidelines will open later in 2016.
Charcot-Marie-Tooth disease (CMT) is the most common inherited nerve disorder, affecting children and adults. It is characterised by progressive motor and sensory nerve damage, which leads to weakness and sensory loss in the feet, hands and limbs, as well as foot deformities, ankle instability and difficulties with balance and walking.